May 6, 2008 - Cordis Corp.'s U.S. launch of the SLEEK and SAVVY Long PTA Balloon Dilatation Catheters represents the company's most advanced percutaneous transluminal angioplasty (PTA) balloon catheters.

"These products incorporate our most advanced balloon technology and underscore our commitment to providing physicians with a full range of treatment options for patients with peripheral vascular disease," said Todd M. Pope.

Vascular Insights' recently 510(k) cleared ClariVein infusion catheter is designed for infusion of physician-specified agents in the peripheral vasculature.

ClariVein is a percutaneous, 2 2/3 Fr (0.035-inch) catheter, containing a rotating wire driven by a motor, that enhances fluid dispersion in the treatment area.

May 6, 2008 - Philips' IntelliVue mobile viewer application gives physicians access to patient information from anywhere within the hospital by providing patient data and alerts through a personal digital assistant (PDA) device.

May 6, 2008 - Cordis Corp. U.S. launch of the SLEEK and SAVVY Long PTA Balloon Dilatation Catheters, representing the company's most advanced percutaneous transluminal angioplasty (PTA) balloon catheters.

"These products incorporate our most advanced balloon technology and underscore our commitment to providing physicians with a full range of treatment options for patients with peripheral vascular disease," said Todd M. Pope.

May 5, 2008 — The FDA has notified GE Healthcare’s Surgery Business that the company has satisfied the criteria in the January 2007 consent decree required to resume operations, and can distribute the OEC 9900 Elite C-arm.

The 9900, a fluoroscopy device that uses x-rays to reveal real-time imagery of a patient’s internal structure, is the first product to receive manufacturing and shipping authorization. More than 300 of these units will be shipped to customers in the first 10 days of operations.

May 5, 2008 - Questions on what tools, systems and technology are needed to successfully automate anticoagulation therapy management will be addressed in the complimentary webinar "Leveraging CVIS Integration to Automate Anticoagulation Therapy: Steps to Achieving Data Automation, Single-Source Documentation, 24-7 Multi-User Access," held on Thursday, May 15, 10 am PDT.

May 5, 2008 - The echocardiography laboratories at Children's Hospitals and Clinics of Minnesota with Children's Heart Clinic received national accreditation in pediatric transthoracic echocardiography from the Intersocietal Commission for the Accreditation of Echocardiography Laboratories (ICAEL), in recognition of its quality care and diagnostic testing.

The laboratories are part of Children's Cardiovascular Services, a collaboration with Children's Heart Clinic. Children's labs are the first and only in Minnesota to receive such accreditation.

May 5, 2008 - The FDA has notified GE Healthcare's Surgery Business that the company has satisfied the criteria in the January 2007 consent decree required to resume operations, and can distribute the OEC 9900 Elite C-arm.

The 9900, a fluoroscopy device that uses X-rays to reveal real-time imagery of a patient's internal structure, is the first product to receive manufacturing and shipping authorization. More than 300 of these units will be shipped to customers in the first 10 days of operations.

After GE Healthcare implemented enhancements to the OEC 9900 Elite C-arm, a fluoroscopy device that uses x-rays to reveal real-time imagery of a patient's internal structure, it filed a new 510(k) for the unit.

The 9900 Elite C-arm, the company's flagship C-arm offers a fully-motorized option designed to give the user complete control of the C-arm's lateral and orbital movements at 9 degrees per second – right from the tableside control panel with an easy-to-use joystick. A collision protection system provides both audible and visual warnings when it detects contact.

May 1, 2008 - High-amplitude electrogram T-wave alternans often precedes spontaneous ventricular tachycardia (VT) and ventricular fibrillation (VF) in humans, and can be detected by measuring stored data directly from implantable cardioverter-defibrillators (ICDs), according to a new study published in the May issue of HeartRhythm, the official journal of the Heart Rhythm Society,

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now